Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: Results of the CANWARD 2007-2009 study

Diagnostic Microbiology and Infectious Disease

Volumn 69, Issue 3, 2011, Pages 291-306

  Zhanel, George G ^a   Adam, Heather J ^a,b   Low, Donald E ^c   Blondeau, Joseph ^d   DeCorby, Melanie ^a   Karlowsky, James A ^a,b   Weshnoweski, Barbara ^b   Vashisht, Ravi ^a   Wierzbowski, Aleksandra ^a   Hoban, Daryl J ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Diagnostic Services of Manitoba Inc   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

Antimicrobial; Hospitals; Susceptibility

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CARBAPENEM DERIVATIVE; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COLISTIN; COTRIMOXAZOLE; DAPTOMYCIN; DORIPENEM; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MEROPENEM; MOXIFLOXACIN; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; TIGECYCLINE; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CANADA; ENTEROBACTER CLOACAE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HOSPITAL; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STAPHYLOCOCCUS EPIDERMIDIS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; TERTIARY HEALTH CARE; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BETA-LACTAMASES; CANADA; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE COCCI; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; VANCOMYCIN RESISTANCE;

EID: 79951924309     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.10.025     Document Type: Article

References (31)

1. Biedenbach D.J., Moet G.J., Jones R.N. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY antimicrobial surveillance program (1997-2002). Diagn. Microbiol. Infect. Dis. 2004, 50:59-69.
2. Castanheira M., Sader H.S., Jones R.N. Antimicrobial susceptibility patterns of KPC-producing or CTX-M-producing Enterobacteriaceae. Microb. Drug Resist. 2010, 16:61-65.
3. Christianson S., Golding G.R., Campbell J., The Canadian Nosocomial Infection Surveillance Program, Mulvey M.R. Comparative genomics of Canadian epidemic lineages of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 2007, 45:1904-1911.
4. Clinical and Laboratory Standards Institute Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: 8th Edition. M7-A8 2009, CLSI, Wayne, PA.
5. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twentienth informational supplement. M100-S20 2010, CLSI, Wayne, PA.
6. Deshpande L.M., Fritsche T.R., Moet G.J., Biedenbach D.J., Jones R.N. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: A report from the SENTRY antimicrobial surveillance program. Diagn. Microbiol. Infect. Dis. 2007, 58:163-170.
7. Eliopoulos G.M. Microbiology of drugs for treating multiply drug-resistant Gram- positive bacteria. J. Infect. 2009, 59:S17-S24.
8. Farrell D.J., Mendes R.E., Ross J.E., Jones R.N. Linezolid surveillance program results for 2008 (LEADER program for 2008). Diagn. Microbiol. Infect. Dis. 2009, 65:392-403.
9. Farrell D.J., Sader H.S., Jones R.N. Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections. Antimicrob. Agents Chemother. 2010, 54:2735-2737.
10. Golding G., Campbell J., Spreitzer D., Veyhl J., Surynicz K., Simor A., Mulvey M.R., Canadian Nosocomial Infection Surveillance Program A preliminary guideline for the assignment of methicillin-resistant Staphylococcus aureus to a Canadian pulsed-field electrophoresis epidemic type using spa typing. Can. J. Infect. Dis. Med. Microbiol. 2008, 19:273-281.
11. Hoban D.J., Zhanel G.G. Introduction to the CANWARD study, 2007-2009. Diagn Microbiol Infect Dis 2011, 69:289-290.
12. Jones R.N., Stilwell M.G., Rhomberg P.R., Sader H.S. Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY antimicrobial surveillance program (1997-2007). Diagn. Microbiol. Infect. Dis. 2009, 65:331-334.
13. Jones R.N., Ross J.E., Bell J.M., Utsuki U., Fumiaki I., Kobayashi I., Turnidge J.D. Zyvox annual appraisal of potency and spectrum program: linezolid surveillance program results for 2008. Diagn. Microbiol. Infect. Dis. 2009, 65:404-413.
14. Lockhart S.R., Abramson M.A., Beekmann S.E., Gallagher G., Riedel S., Diekema D.J., Quinn J.P., Doern G.V. Antimicrobial resistance among Gram-negative bacilli as causes of infections in intensive care unit patients in the United States between 1993-2004. J. Clin. Microbiol. 2007, 45:3352-3359.
15. Mulvey M.R., Chiu L., Ismail J., Louie L., Murphy C., Chang N., Alfa M., the Canadian Committee for the Standardization of Molecular Methods Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. J. Clin. Microbiol. 2001, 39:3481-3485.
16. Mulvey M.R., MacDougall L., Cholin B., Horsman G., Fidyk M., Woods S. Community-associated methicillin-resistant Staphylococcus aureus. Canada Emerg. Infect. Dis. 2005, 11:844-850. the Saskatchewan CA-MRSA Study Group.
17. Oliveira D.C., de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2002, 46:2155-2161.
18. Putnam S.D., Sader H.S., Farrell D.J., Jones R.N. Sustained antimicrobial activity of tigecycline against methicillin-resistant Staphylococcus aureus (MRSA) from United States medical centres from 2004 through 2008. J. Chemother. 2010, 22:13-16.
19. Rhomberg P.R., Jones R.N. Summary trends for the meropenem yearly susceptibility test information collection program: a 10 year experience in the United States (1999-2008). Diagn. Microbiol. Infect. Dis. 2009, 65:414-426.
20. Rubinstein E., Zhanel G.G. Anti-infectives research and development problems challenges and solutions: The clinical practitioner perspective. Lancet Infect. Dis. 2007, 7:69-70.
21. Sader H.S., Jones R.N. Antimicrobial susceptibility Gram-positive bacteria isolated from US medical centres: Results of the daptomycin surveillance program (2007-2008). Diagn. Microbiol. Infect. Dis. 2009, 65:158-162.
22. Sader H.S., Becker H.K., Moet G.J., Jones R.N. Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008). Diagn. Microbiol. Infect. Dis. 2010, 66:329-331.
23. Simor A.E., Louie L., Watt C., Gravel D., Mulvey M.R., Campbell J., McGeer A., Bryce E., Loeb M., Matlow A. Antimicrobial susceptibilities of healthcare-associated and community-associated strains of methicillin-resistant Staphylococcus aureus from hospitalized patients in Canada 1995-2008. Antimicrobial. Agents Chemother. 2010, 54:2265-2268.
24. Walkty A., DeCorby M., Nichol K., Karlowsky J.A., Hoban D.J., Zhanel G.G. In vitro activity of colistin (polymyxin E) against 3480 isolates of Gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD study 2007-2008. Antimicrob. Agents Chemother. 2009, 53:4924-4926.
25. Wang Y.F., Dowzicky M.J. In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the tigecycline evaluation and surveillance trial, 2004 to 2008. Diagn. Microbiol. Infect. Dis. 2010, 68:73-79.
26. Wilson J., Elgohari S., Livermore D.M., Cookson B., Johnson A., Lamagni T., Chronias A., Sheridan E. Trends among pathogens reported as causing bacteraemia in England, 2004 to 2008. Clin. Microbiol. Infect. 2010, May 18 (Epub ahead of print).
27. Zhanel G.G., Dilay R.L., Thompson K., Rubinstein E., Hoban D.J., Karlowsky J.A. A review of the carbapenems. Drugs 2007, 67:1027-1052.
28. Zhanel G.G., DeCorby M., Nichol K.A., Wierzbowski A., Baudry P.J., Karlowsky J.A., Lagace-Wiens P., Walkty A., Mulvey M.R., Hoban D.J., The Canadian Antimicrobial Resistance Alliance Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006. Diagn. Microb. Infect. Dis. 2008, 62:67-80.
29. Zhanel G.G., DeCorby M., Nichol K.A., Baudry P.J., Karlowsky J.A., Lagace-Wiens P.R., McCracken M., Mulvey M.R., Hoban D.J. Characterization of methicillin-resistant Staphylococcus aureus vancomycin-resistant enterococci and extended spectrum beta-lactamase producing Escherichia coli in intensive care units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005/2006. Can. J. Infect. Dis. Med. Microbiol. 2008, 19:243-249.
30. Zhanel G.G., DeCorby M., Laing N., Wierzbowski A., Vashisht R., Tailor F., Nichol K., Wierzbowski A., Baudry P.J., Karlowsky J.A., Lagace-Wiens P., Walkty A., McCracken M., Mulvey M.R., Johnson J., The Canadian Antimicrobial Resistance Alliance, Hoban D.J. Antimicrobial resistant pathogens in intensive care units across Canada: results of the Canadian National Intensive Unit (CAN-ICU) study, 2005/6. Antimicrob. Agents Chemother. 2008, 52:1430-1437.
31. Zhanel G.G., DeCorby M., Adam H., Mulvey M.R., McCracken M., Lagace-Wiens P.R., Nichol K.A., Wierzbowski A., Baudry P.J., Tailor F., Karlowsky J.A., Walkty A., Schweizer F., Johnson J., The Canadian Antimicrobial Resistance Alliance (CARA), Hoban D.J. Prevalence of antimicrobial resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008). Antimicrob. Agents Chemother. 2010, 54:4684-4693.